243 related articles for article (PubMed ID: 17003289)
41. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
42. Triphenyltin impairs a protein kinase A (PKA)-dependent increase of cytosolic Na+ and Ca2+ and PKA-independent increase of cytosolic Ca2+ associated with insulin secretion in hamster pancreatic beta-cells.
Miura Y; Matsui H
Toxicol Appl Pharmacol; 2006 Nov; 216(3):363-72. PubMed ID: 16837018
[TBL] [Abstract][Full Text] [Related]
43. Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs.
Okamoto M; Ogihara N; Kawamura W; Ebihara S; Takiguchi K; Morita T; Uchida R; Yamaguchi J; Sakai T; Okuda Y; Hayashi Y; Arakawa Y; Kikuchi M
Metabolism; 2002 May; 51(5):575-81. PubMed ID: 11979388
[TBL] [Abstract][Full Text] [Related]
44. The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage-dependent K
Li H; Kim HW; Shin SE; Seo MS; An JR; Jung WK; Ha KS; Han ET; Hong SH; Bang H; Choi IW; Na SH; Park WS
Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 28834298
[TBL] [Abstract][Full Text] [Related]
45. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Biochem Biophys Res Commun; 2000 Apr; 271(1):234-9. PubMed ID: 10777708
[TBL] [Abstract][Full Text] [Related]
46. Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line.
Puddu A; Salani B; Cordera R; Viviani GL; Maggi D
Biochem Biophys Res Commun; 2008 Oct; 375(2):235-7. PubMed ID: 18703018
[TBL] [Abstract][Full Text] [Related]
47. Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells.
Saïfia S; Chevrier AM; Bosshard A; Cuber JC; Chayvialle JA; Abello J
J Endocrinol; 1998 Apr; 157(1):33-41. PubMed ID: 9614355
[TBL] [Abstract][Full Text] [Related]
48. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
49. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
McLeod JF
Clin Pharmacokinet; 2004; 43(2):97-120. PubMed ID: 14748619
[TBL] [Abstract][Full Text] [Related]
50. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
Shibasaki T; Takahashi T; Takahashi H; Seino S
Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
[TBL] [Abstract][Full Text] [Related]
51. Acute effect of 3β-hidroxihop-22(29)ene on insulin secretion is mediated by GLP-1, potassium and calcium channels for the glucose homeostasis.
Castro AJ; Cazarolli LH; de Carvalho FK; da Luz G; Altenhofen D; dos Santos AR; Pizzolatti MG; Silva FR
J Steroid Biochem Mol Biol; 2015 Jun; 150():112-22. PubMed ID: 25843210
[TBL] [Abstract][Full Text] [Related]
52. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
Green BD; Gault VA; O'Harte FP; Flatt PR
Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
[TBL] [Abstract][Full Text] [Related]
53. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
Kikuchi M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S151-5. PubMed ID: 8894500
[TBL] [Abstract][Full Text] [Related]
54. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
Damholt AB; Buchan AM; Kofod H
Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
[TBL] [Abstract][Full Text] [Related]
55. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
56. cAMP-independent effects of GLP-1 on β cells.
Kolic J; MacDonald PE
J Clin Invest; 2015 Dec; 125(12):4327-30. PubMed ID: 26571393
[TBL] [Abstract][Full Text] [Related]
57. Contrasting effects of nateglinide and rosiglitazone on insulin secretion and phospholipase C activation.
Zawalich WS; Tesz G; Zawalich KC
Metabolism; 2003 Nov; 52(11):1393-9. PubMed ID: 14624396
[TBL] [Abstract][Full Text] [Related]
58. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
[TBL] [Abstract][Full Text] [Related]
59. Rebaudioside A directly stimulates insulin secretion from pancreatic beta cells: a glucose-dependent action via inhibition of ATP-sensitive K-channels.
Abudula R; Matchkov VV; Jeppesen PB; Nilsson H; Aalkjaer C; Hermansen K
Diabetes Obes Metab; 2008 Nov; 10(11):1074-85. PubMed ID: 18435771
[TBL] [Abstract][Full Text] [Related]
60. Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in rats.
Iwase M; Nakamura U; Uchizono Y; Nohara S; Sasaki N; Sonoki K; Iida M
Eur J Pharmacol; 2005 Aug; 518(2-3):243-50. PubMed ID: 16023099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
